← Back to home

For contrast-enhanced magnetic resonance imaging (MRI) of central nervous system (CNS) lesions

Clinical trials for For contrast-enhanced magnetic resonance imaging (MRI) of central nervous system (CNS) lesions explained in plain language.

Never miss a new study

Get alerted when new For contrast-enhanced magnetic resonance imaging (MRI) of central nervous system (CNS) lesions trials appear

Sign up with your email to follow new studies for For contrast-enhanced magnetic resonance imaging (MRI) of central nervous system (CNS) lesions, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New MRI dye aims to sharpen brain scan images

Diagnosis Completed

This phase 3 trial tests a new contrast agent called HRS-9231 for MRI scans of the brain and spine. The goal is to see if it works as well as the standard contrast agent (gadobutrol) at making lesions visible. About 250 adults with known or suspected brain or spine lesions will r…

Matched conditions: FOR CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF CENTRAL NERVOUS SYSTEM (CNS) LESIONS

Phase 3 • Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd • Aim: Diagnosis

Last updated Jul 02, 2026 00:00 UTC

For contrast-enhanced magnetic resonance imaging (MRI) of central nervous system (CNS) lesions

Get alerted when new For contrast-enhanced magnetic resonance imaging (MRI) of central nervous system (CNS) lesions trials appear

New MRI dye aims to sharpen brain scan images